Christina Rossi Blueprint Medicines Corp (BPMC) insider trading activity

Christina Rossi is CHIEF OPERATING OFFICER of Blueprint Medicines Corp. Currently has a direct ownership of 69,383 shares of BPMC, which is worth approximately $6.28 Million. The most recent transaction as insider was on Dec 18, 2024, when has been sold 2,274 shares (Common Stock) at a price of $96.19 per share, resulting in proceeds of $218,736. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 69.4K

6.15% 3M change

25.29% 12M change

Total Value Held $6.28 Million

Christina Rossi Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 18 2024	SELL Open market or private sale	$218,736 $96.19 p/Share	2,274 Reduced 3.17%	69,383 Common Stock
Nov 27 2024	SELL Open market or private sale	$216,257 $95.1 p/Share	2,274 Reduced 3.08%	71,657 Common Stock
Jul 01 2024	BUY Grant, award, or other acquisition	-	9,625 Added 11.52%	73,931 Common Stock
Mar 07 2024	SELL Open market or private sale	$550,488 $90.69 p/Share	6,070 Reduced 8.63%	64,306 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	15,000 Added 17.57%	70,376 Common Stock
Mar 06 2023	SELL Open market or private sale	$137,655 $45.0 p/Share	3,059 Reduced 5.23%	55,376 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	15,000 Added 20.43%	58,435 Common Stock
Nov 03 2022	SELL Open market or private sale	$24,112 $45.24 p/Share	533 Reduced 1.21%	43,435 Common Stock
Mar 07 2022	SELL Open market or private sale	$58,831 $56.19 p/Share	1,047 Reduced 2.3%	44,479 Common Stock
Mar 03 2022	SELL Open market or private sale	$72,155 $60.28 p/Share	1,197 Reduced 2.56%	45,526 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	15,000 Added 24.3%	46,723 Common Stock
Nov 03 2021	SELL Open market or private sale	$56,644 $110.85 p/Share	511 Reduced 1.15%	43,968 Common Stock
Mar 04 2021	SELL Open market or private sale	$119,402 $87.86 p/Share	1,359 Reduced 4.11%	31,723 Common Stock
Mar 01 2021	BUY Grant, award, or other acquisition	-	13,062 Added 28.31%	33,082 Common Stock
Nov 03 2020	SELL Open market or private sale	$34,393 $99.69 p/Share	345 Reduced 1.69%	20,020 Common Stock

Also insider at

XLO

Xilio Therapeutics, Inc. Healthcare

Christina Rossi

CHIEF OPERATING OFFICER

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BPMC shares.

Notify only if

Value

Insider Trading

Get notified when an Blueprint Medicines Corp insider buys or sells BPMC shares.

Notify only if

Operation

Value

Type

News

Receive news related to Blueprint Medicines Corp

Track Activities on BPMC

Account